A rare cause of chronic lymphadenopathy with pancytopenia in an infant

Introduction
Autoimmune lymphoproliferative syndrome (ALPS) is the first human disease whose aetiology has been attributed to a primary defect in apoptosis or programmed cell death. ALPS is a rare disorder in children characterized by splenomegaly, massive lymphadenopathy, autoimmune phenomena such as thrombocytopenia, neutropenia, haemolytic anemia and accumulation of double-negative (CD3+CD4-CD8-) T cells in the blood 1, 2 . In the majority of patients ALPS occurs due to inherited mutations in genes encoding proteins of the Fas pathway, which mediates programmed cell death or apoptosis 3 .
Case report
A one year old boy presented with hepatosplenomegaly, anaemia and neutropenia. His complaints began at seven months of age and were gradually progressive. He was born of a thirddegree consanguineous marriage. Physical examination revealed pallor, significant cervical lymphadenopathy, firm hepatomegaly of 2cm and a spleen of 3cm. Developmental status and other systemic examinations were normal. His blood count showed a hypochromic, microcytic anaemia (hemoglobin level of 7 g/dl), thrombocytopenia (platelet count of 19,000/µl) and neutropenia (white blood cell count of 5,500/µl with an absolute neutrophil count of 330), thus indicating pancytopenia. The liver function tests, lipid profile and serum immunoglobulin levels were unremarkable and tuberculin test was negative. Direct and indirect Coombs tests were negative. Bone marrow biopsy showed mild cellular hyperplasia and increased megakaryocytes. Serologic evaluation for infectious diseases such as HIV, EBV, CMV, HCV and HBV were negative. Serum Vitamin B12 levels were high (1900 ng/L).Chest radiography and abdominal ultrasound were unremarkable. Autoimmune markers (ANA and ds DNA) were negative. Immunophenotyping showed normal lymphocytes. Peripheral blood The patient fulfilled two required criteria and two supportive criteria, thus establishing the diagnosis of ALPS. He was treated with oral prednisolone (1mg/kg/day) for a period of two months with a significant decrease in the size of lymph nodes and an increase in platelet count on follow-up.
Discussion
To the best of our knowledge, very few cases of ALPS have been reported in South-East Asia, especially in the Indian subcontinent. The immune response to infectious agents results in the expansion of antigen-specific lymphocytes, some of which could become harmful to the host. The maintenance of proper homeostasis requires that lymphocyte expansion be appropriately balanced by lymphocyte elimination 4 . ALPS is a chronic, nonmalignant lymphoproliferative disorder caused by mutations in the genes that are involved in apoptosis. This impaired apoptosis leads to accumulation of lymphocytes causing lymphadenopathy, autoimmune phenomena and a high risk of developing malignant lymphomas. Most of the patients manifest between six months to 18 years. The most common autoimmune disorder is immune thrombocytopenic purpura (ITP) and haemolytic anaemia. There is also accumulation of phenotypically normal CD3+, CD4-, CD8-T cells (CD3+ DNT). 5 Autosomal recessive and dominant mutations have been described 6 
